Oncology

FDA approval confirms that ExAblate® MRI-guided Focused Ultrasound is effective in reducing pain from bone metastases in patients who could not undergo radiation therapy.

A new study demonstrates the potential for use of Dune Medical’s MarginProbe system in surgical margin assessment during radical prostatectomy procedures.

Californian radiotherapy company Varian Medical Systems’ President and CEO Timothy Guertin has declared his intention to retire from the role after 35 years with the company.

St. James’s University Hospital, Leeds, UK, harnesses Elekta’s Agility multileaf collimator (MLC) and Elekta VMAT to treat patient with tongue cancer

Swedish medtech company, SciBase, has announced positive results from its pivotal study of Nevisense, a unique non-invasive point-of-care device for detection of Malignant Melanoma.

Cook Medical has gained 510(k) clearance for its Evolution® Colonic Controlled-Release Stent. The new stent is used to palliate uncomfortable symptoms associated with colonic obstructions caused by malignant neoplasms and relieve large-bowel obstructions prior to colectomy procedures.

Cleveland medical device company ViewRay Inc., has received U.S. FDA 510(k) premarket notification clearance for its MRI-guided radiation therapy system. The ViewRay system features what the company calls a unique combination of radiotherapy delivery and simultaneous magnetic resonance imaging (MRI) for the treatment of cancer.

Cook’s range of fine needle biopsy histology needles is enhanced by the addition of this new 25gauge iteration, which, according to the company, is the smallest gauge endoscopy needle available today.
Let’s not argue about how to spell gauge by the way.

Covidien has unveiled its new range add HALO 90 ULTRA for ablative treatment of large Barrett’s Oesophagus lesions. The device, which comes from the stable of recently acquired Barrx Medical, is double the length of its HALO 90 brother and as such can reduce ablation treatment time and in so doing shorten the procedure.

Millennium Research Group believes strong growth in Radioembolization Spheres, Drug-Eluting Beads and Flow-Diverting Devices will result in a 5.5% annual market growth rate through 2016.

They’re all at it… joining forces to extend sales of their own products while also sharing future NPD expenditure is medtech’s very own definition of a developing symbiotic relationship between closely related businesses.

Accuray takes on da-Vinci in the quest to establish the gold standard of treatment for early stage localised prostate cancer. Ten year multicentre study announced.

Top universities really do churn out some brilliant work. In this case Stanford researchers have published on the use of coated gold nanoparticles which selectively find cancer cells and aid in their isolation for treatment, potentially improving accuracy with the benefit of minimising collateral damage and ensuring no cancer remains.

Stereotactic Radiosurgery techniques are at the forefront of events at this week’s AANS meeting. Varian Medical Systems Inc is demonstrating its wares in what is becoming the gold standard treatment option in specific brain and spinal tumors.

Covidien’s November 2011 acquisition of BARRX Medical Inc is followed now by the launch of a new dimension catheter to make treatment of Barrett’s Esophagus easier.

Christopher Lyles, the first American recipient of a seeded tracheal transplant has passed away this week.